Astrid Belalcazar, MD
Hematology & Oncology Physician · Montgomery, AL
Astrid Belalcazar, MD is a hematology & oncology physician with a practice address in Montgomery, Alabama, and NPI 1740578905, issued on Jul 21, 2011. Check the license (Alabama MD.38781, as entered in NPPES) on the Alabama Board of Medical Examiners; the Medicare figures below come from public CMS files.
- Name
- Astrid Belalcazar
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- MD.38781 AL
Self-reported in NPPES; status is on the state search - Practice location
- 300 Saint Lukes Dr, Montgomery, AL 36117
- Phone
- (334) 273-8877
- Enumerated
- Jul 21, 2011
- Record last updated
- Jun 24, 2020 (not updated in 6 years: call before relying on the address or phone)
- Medicare enrollment
- Enrolled (PECOS I20191211003347); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 191 in Alabama → Look up another NPI →
Also registered at 300 Saint Lukes Dr
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Thomas Beatrous, MDRadiation Oncology Physician1306853700
Verify Astrid Belalcazar in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersAlabama Board of Medical Examiners
Search for license MD.38781Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
2% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
861 Medicare Part D claims for 114 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 45% of claims. 25 claims were for opioids.
Most prescribed
- Letrozole60 claims
- Procrit56 claims
- Xgeva36 claims
- Keytruda31 claims
- Bortezomib26 claims
- Anastrozole25 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $525.37
22 payments; by number, the most common kind was food and beverage; the largest payer was Celgene Corporation. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Alabama Cancer Care, LLCMontgomery, AL
- Houston County Healthcare AuthorityDothan, AL
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Astrid Belalcazar among 191 hematology & oncology physician records in Alabama
Astrid Belalcazar, MD is one of 191 hematology & oncology physician records with a practice address in Alabama. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2011, is newer than 68% of them.
- NPI issued2011 · 68% of these records are older, 30% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 80% of these records are
- Graduated2007 · median 2006 among the 153 with a school on file
- Record last updated2020 · 40% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Alabama practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Alabama
There are 191 hematology & oncology physician records in Alabama.
All 191 in Alabama → Every provider in Montgomery → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Nino Aleksidze, M.D.Montgomery, AL 361061427438530
- Harry Barnes, MDMontgomery, AL 361061356395214
- William Cumbie, MDMontgomery, AL 361061053303602
- Stephen Davidson, MDMontgomery, AL 361061902852171
- Rachelle Hamadi, MDMontgomery, AL 361061780246868
- Scott McDaniel, MDMontgomery, AL 361061780623850
- John Reardon, MDMontgomery, AL 361061679786354
- Jackson Reynolds, MDMontgomery, AL 361061689036048
Common questions
What is Astrid Belalcazar, MD's NPI number?
Astrid Belalcazar, MD's National Provider Identifier (NPI) is 1740578905, issued on Jul 21, 2011. An NPI identifies a provider in billing; it is not a license.
Where is Astrid Belalcazar, MD located?
The NPPES record lists a practice address at 300 Saint Lukes Dr, Montgomery, AL, 36117. Phone: (334) 273-8877. Providers update this record themselves, so call before visiting.
How can I verify Astrid Belalcazar, MD's license?
NPPES lists Alabama license number MD.38781, as entered by the provider. Search the Alabama Board of Medical Examiners at https://www.albme.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Astrid Belalcazar, MD prescribe under Medicare Part D?
In 2024, Astrid Belalcazar, MD had 861 Medicare Part D claims for 114 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.